- RecruitingPHASE2
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
This study looks at a new treatment called rapcabtagene autoleucel for severe forms of a condition called ANCA-Associated Vasculitis (AAV), specifically GPA and MPA. It aims to see how well it works and if it's safe compared to current treatments.
For: ANCA Associated Vasculitis (AAV)United States · Brazil · Israel - Active not recruitingPHASE2
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
This study is looking into a new medication called Nipocalimab for people with active inflammatory myopathies, a condition that causes muscle weakness and inflammation. It aims to see if Nipocalimab is safe and helps more than a dummy treatment.
For: MyositisUnited States · Canada · Czechia